Healthtech & Wellness VC Funds

Pangaea Ventures is a world-leading hard-technology venture capital firm founded in 2000 by Founding General Partner Chris Erickson (formerly a partner at Osler, Hoskin and Harcourt specializing in environmental and corporate law), Purnesh Seegopaul, and David Weekes. Headquartered in Vancouver, British Columbia with an additional office in Phoenix, Arizona, the firm backs early-stage companies leveraging advancements in advanced materials, chemistry, and biology to address large global challenges and enable a sustainable future. Across five funds, the firm has targeted multi-trillion-dollar market opportunities in energy, electronics, health, and sustainability. Fund IV was a $100 million vehicle, and Fund V, the Pangaea Ventures Impact Fund, held its final close in April 2024 at CAD 115 million, planning approximately 10 to 12 Series A investments with typical checks of $3 million to $5 million. Pangaea leads rounds and operates with a team of 16, including six partners such as Andrew Haughian, who joined in 2006 and leads materials-science coverage. The firm has invested in 42 companies and has recorded 12 portfolio exits to date. Portfolio highlights include Aspect Biosystems (bioprinted tissue), Calysta (gas-fermentation protein), CarbonCure (carbon-sequestering concrete, with $169 million-plus raised), ESS (iron flow batteries), Redlen Technologies (medical imaging), Vestaron (bio-pesticides), and Nautilus Data Technologies. In 2025 the firm completed three new investments, with the most recent being pH7 Technologies' Series B in December 2025. Pangaea Ventures brings deep technical diligence capability, scientific networks, and long-duration patient capital to founders commercializing laboratory breakthroughs in materials and chemistry. Its specialist positioning within hard tech makes it one of the few funds globally with the expertise and conviction to lead seed and Series A rounds in the advanced-materials category.

Panoramic Ventures, also known as BIP Ventures, is a venture capital firm that invests in early-stage and growth-stage technology companies. With a strong focus on supporting the innovation economy, Panoramic Ventures partners with entrepreneurs to build impactful businesses across diverse industries. Founded as BIP Capital, the firm has a robust portfolio and offers comprehensive private market investment solutions. Their investment strategy is centered around identifying high-potential startups and providing them with the necessary capital and strategic guidance to scale successfully. Panoramic Ventures has a notable portfolio of companies, including OncoLens, which specializes in oncology management solutions, and Acclivity Health Solutions, which focuses on improving end-of-life care through advanced technology platforms.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Pappas Capital is a prominent venture capital firm based in Durham, North Carolina, specializing in investing in next-generation life science, agriculture, and technology companies. Established in 1994 by Art Pappas, the firm has a robust track record of investing in over 90 companies across the United States, Canada, and Asia. Their investments focus on innovative solutions that address significant unmet medical needs and span a wide range of diseases, including cancer and hemophilia​. Pappas Capital operates through three primary divisions: Pappas Ventures, Specialized Fund Management, and Translational Medicine. Pappas Ventures is their flagship arm, dedicated to life science investments, particularly in undercapitalized markets. Specialized Fund Management creates and manages custom investment vehicles, while Translational Medicine partners with academic institutions to accelerate the development of scientific discoveries. The firm boasts a seasoned team of investment professionals, including Art Pappas, Elizabeth Kelly, and Barry Myers, who bring extensive experience in pharmaceuticals, biotechnology, and venture capital. This expertise enables Pappas Capital to provide valuable insights and strategic guidance to their portfolio companies, helping them navigate the complexities of drug development and commercialization. Pappas Capital has successfully guided numerous companies to significant exits, including IPOs and acquisitions. Recent investments include companies like VFlow Tech and Enlaza Therapeutics, further emphasizing their commitment to advancing groundbreaking life science technologies​.

Pareto Holdings, founded by Edward Lando and Jon Oringer in 2020, is a Miami-based venture capital firm specializing in early-stage investments. The fund has a dynamic portfolio that includes notable companies such as Burnbot, nsave, and Elevated Signals, reflecting its focus on Environmental Services (B2B), Financial Software, and Business/Productivity Software industries. Pareto Holdings primarily targets startups with high potential for globalization, emphasizing early growth companies with significant momentum. Geographically, the firm maintains a strong presence in the U.S., with a particular focus on the Miami entrepreneurial ecosystem. The investment strategy at Pareto Holdings involves being one of the first backers of exceptional entrepreneurs. They typically lead funding rounds and are known for their active involvement in their investments. The average check size varies, but they maintain a hands-on approach, often participating in the operational aspects of the startups they invest in. Approaching Pareto Holdings requires demonstrating high growth potential and a clear path to global expansion. They value innovation and market disruption, looking for teams that can leverage their extensive network and resources effectively. The leadership team at Pareto Holdings includes Edward Lando, Jon Oringer, Rohit Bhadange, Annie Wasserman, and Benjamin-Jean Cambier, all based in Miami. This diverse team brings a wealth of experience in venture capital and business development, ensuring robust support for their portfolio companies.

Pari Passu Venture Partners (PPVP) is a founder-led, early-stage venture capital firm that invests at the intersection of technology and retail. With a focus on companies that demonstrate strong product-market fit, PPVP invests primarily in pre-seed to Series B rounds, offering checks ranging from $250,000 to $3 million. The firm is driven by a commitment to supporting exceptional founders by providing them with not just capital but also deep operational expertise, particularly in e-commerce and SaaS businesses. Led by Julia Gudish Krieger, Dylan Whitman, and Kyle Widrick, PPVP leverages its team's experience in building successful companies like BVA Commerce and Win Brands Group. This background gives them a unique perspective and access to highly curated deal flow, often allowing them to invest in oversubscribed rounds alongside top-tier funds like Sequoia and Upfront Ventures. PPVP’s portfolio includes companies across various sectors, such as Siena AI, a customer service automation platform, and EdSights, an edtech company focused on student retention. The firm also launched a co-investment network called PariPassu, which allows accredited investors to easily co-invest in high-potential startups through a user-friendly app. This platform enables investors to engage directly with founders and access exclusive deal opportunities, further amplifying the value PPVP brings to the table for both entrepreneurs and investors alike.

Parkwalk Advisors, founded in 2009, is a leading UK-based growth fund manager specializing in investments in university spin-outs. With over £500 million raised and investments in more than 180 companies, Parkwalk focuses on high-growth, knowledge-intensive sectors such as AI, big data, life sciences, cleantech, and quantum computing. Parkwalk's notable portfolio companies include Bramble Energy, a clean energy technology provider; AccelerComm, a semiconductor chip design company; and PetMedix, a veterinary biopharmaceutical company. These investments highlight Parkwalk's commitment to fostering innovation in deep tech and science sectors. The firm manages various funds, including the Parkwalk Opportunities EIS Fund and the Knowledge Intensive EIS Funds, which offer tax benefits under the Enterprise Investment Scheme (EIS). These funds aim to support the commercialization of technologies emerging from the UK's top universities, such as Oxford, Cambridge, Imperial College, and UCL. Parkwalk's approach to investing includes providing strategic support and leveraging their extensive network to help portfolio companies achieve their full potential. They have been the largest single EIS fundraise for several years, demonstrating their pivotal role in the UK’s venture capital landscape.

Partech is a global venture capital firm with a strong focus on technology startups, operating across several investment stages—Seed, Venture, Growth, and Impact. Its portfolio includes notable companies such as Akeneo, a leader in product information management, and ManoMano, Europe's top online marketplace for DIY and gardening products. With offices in San Francisco, Paris, Berlin, and Dakar, Partech invests worldwide, with a special focus on Europe and Africa. The firm’s seed-stage investments typically range from €300k to €3M, with Partech taking a hands-on approach to support startups from the earliest stages. In the growth phase, they invest larger amounts—up to €100M—to scale high-growth companies like Rohlik Group, a rapidly expanding online grocery delivery service. Partech also leads the way in African tech investments, backing companies such as Wave Sénégal, a leading mobile money provider. Their impact fund focuses on scaling companies addressing environmental and social challenges, with investments ranging from €15M to €40M.

Passion Capital, founded in 2011 and based in London, is a prominent early-stage venture capital firm focusing on technology startups. The firm was established by Eileen Burbidge, Robert Dighero, and Stefan Glaenzer, all successful entrepreneurs. Passion Capital is known for its hands-on approach, providing not only funding but also mentorship and strategic advice to its portfolio companies. Passion Capital has a strong track record of backing successful startups, including well-known names like Monzo, the digital bank; GoCardless, a payment processing company; and Lendable, a platform for personal loans. They invest primarily in sectors such as information technology, TMT (Technology, Media, and Telecommunications), IoT (Internet of Things), mobile, infrastructure, and SaaS (Software as a Service) within Europe. The firm typically invests in companies at the seed stage and often leads the funding rounds. Their investment philosophy emphasizes a strong relationship with founders, aiming to support and guide them through the early challenges of scaling their businesses. The founding partners bring extensive experience and have been instrumental in shaping Europe's technology landscape. Passion Capital also made headlines by opening up part of their latest £45 million fund to retail investors via crowdfunding, a first for a European VC firm. This innovative approach reflects their commitment to democratizing access to venture capital investments.

Pathbreaker Ventures, established in 2016 and based in San Francisco, focuses on early-stage investments in startups tackling significant global challenges with innovative hardware and software solutions. Led by Ryan Gembala, the firm supports specialized engineering and product leaders, often investing when a company is still in its foundational stage. Pathbreaker invests in sectors like AI, robotics, and deep tech, targeting problems valued at over $100 billion​. Ryan Gembala, the Founder and Managing Partner, has a rich background in venture capital and corporate development, having previously worked at Facebook and Azure Capital. His experience spans the full startup lifecycle, from founding and operating companies to investing and acquiring venture-backed firms​. Pathbreaker Ventures' portfolio includes companies like Spiketrap, an AI for real-time language understanding, and Mux, which builds video streaming and analytics APIs. The firm co-invests with top-tier venture firms and is known for its hands-on approach, providing capital, strategic advice, and access to a vast network of industry experts.

Patron is an early-stage venture capital firm, launched in 2021 by former Riot Games executives Jason Yeh and Brian Cho. Focused on gaming, consumer internet, and Web3, Patron aims to back founders pioneering the next generation of digital experiences. With its first $90M fund, Patron invested in 21 companies, including notable startups like Kudos and Raid Base, which leverage gaming technologies in creative new ways. The firm recently raised $100M for its second fund, with backing from top investors like Marc Andreessen and Garry Tan. Patron’s mission is built on the belief that gaming will become a major entry point for Web3 and other consumer technologies, from education to personal finance. Patron specializes in leading seed rounds and offers comprehensive support to its portfolio companies, including access to its deep network in gaming and tech. The team brings together over a decade of expertise from companies like Riot Games, Andreessen Horowitz, and FirstMark Capital, making Patron a go-to partner for gaming-native startups looking to scale​.

Paua Ventures, now rebranded as SquareOne, is a Berlin-based venture capital firm that focuses on pre-seed and seed-stage investments. Established in 2010, SquareOne primarily backs B2B tech startups, emphasizing sectors like SaaS, deep tech, and enterprise software. The firm is often the first institutional investor on the cap table, acting as a strategic partner for founders throughout the company's early development stages. SquareOne is known for offering more than just capital. The firm prides itself on being a hands-on partner, providing operational support, mentorship, and valuable connections within its extensive network of executives and industry experts. This proactive involvement helps founders navigate the complexities of scaling their businesses, and many of SquareOne’s portfolio companies go on to secure follow-on funding from top-tier European and U.S. investors. The firm has a strong track record, with notable investments including Pipedrive, Stripe, and Lesara. SquareOne typically invests in European startups but has a global outlook, supporting innovative companies that have the potential to lead in their industries. Christian Buchenau and Moritz Poewe are among the key partners at SquareOne, guiding the firm’s investment strategy and maintaining its reputation as a leading early-stage investor in Europe. By providing a combination of capital, strategic insight, and market access, SquareOne is positioned as a vital player in the European venture capital landscape, helping startups reach their full potential.

PBM Capital, founded by entrepreneur Paul Manning in 2010, is a dynamic healthcare-focused investment firm with a strong emphasis on pharmaceuticals, biotechnology, and life sciences. Headquartered in Charlottesville, Virginia, with an additional office in New York, PBM partners with scientists and innovators to create groundbreaking therapies that significantly improve patient outcomes. Their team provides capital along with critical operational and strategic expertise, helping companies navigate complex healthcare markets and scale rapidly. PBM’s portfolio boasts several notable successes, including AveXis, which was acquired by Novartis for $8.7 billion, and Dova Pharmaceuticals, which completed an IPO before being acquired by Swedish Orphan Biovitrum. The firm seeks out companies with revolutionary science and strong leadership, focusing on areas such as gene therapy, biologics, and drug development. PBM takes an active role in guiding its investments, offering not only funding but also leveraging its extensive network to accelerate commercialization. Their investment strategy centers around long-term value creation, seeking out companies with life-changing technologies and the potential to transform healthcare. By combining operational experience with capital investment, PBM aims to help founders bring revolutionary therapies to market and create lasting impact​.

pd ventures (formerly PDV Inter-Media Venture GmbH) is the corporate venture capital arm of Mediengruppe Pressedruck, the Augsburg-based German media group best known for publishing the Augsburger Allgemeine. Founded in 2009 and headquartered in Augsburg, the firm has invested for more than 15 years in digital media and media-adjacent business models across web services, internet, and mobile applications, with a clear preference for scalable propositions targeting the German DACH market and, selectively, international markets. Founder and Managing Director Renate Dempfle leads the platform alongside Investment Manager Fabio Fiorda. Rather than acting as a pure financial backer, pd ventures explicitly leverages the distribution, reach, and operational synergies of the wider Mediengruppe Pressedruck group where relevant, and offers structures including seed funding, Series A, follow-on, financial investor, media-for-equity, and startup advisory arrangements. The firm has made approximately 20 investments and generated one IPO and eight acquisitions. Notable portfolio and exited companies include Ryte (SaaS content and SEO platform, acquired by Semrush in July 2024 following pd ventures' 2017 investment), Lingoda (online language learning, which had raised $83 million including a $68 million Summit Partners round in April 2021), Asgoodasnew, Spark Networks (IPO), pflege.de, Tausendkind, and Good Hood. pd ventures did not record any new investments in 2025 per public sources. For digital media and consumer internet founders building for the DACH market, pd ventures offers a combination of patient capital, media-industry expertise, and access to one of southern Germany's most established regional media networks, making it a strategic co-investor rather than a passive financial partner.

Peak Capital is a European venture capital firm founded in 2008, focused on early-stage investments in SaaS, marketplaces, and platform businesses. With a fund size of €125 million, Peak backs companies across Europe, particularly in the Nordics, DACH, and Benelux regions. The firm supports its portfolio companies from Pre-Seed to Series B, providing initial investments ranging from €250,000 to €4 million. Peak is distinguished by its founder-funded approach, meaning it is fully backed by successful entrepreneurs. This hands-on, founder-centric philosophy allows Peak to bring deep industry insights and operational expertise to the startups they invest in. The firm tends to lead investment rounds, but they also co-invest when appropriate, offering a wide network of connections for follow-on funding. Peak has made over 50 investments, including companies like Channable, United Wardrobe (acquired by Vinted), and Dyme, focusing on disruptive solutions in e-commerce, SaaS, and digital platforms. Their approach emphasizes strong teams, scalability, and market readiness, avoiding crowded markets or businesses with small ambitions.

Peak State Ventures, founded in 2017 and based in New York City, is a venture capital firm that focuses on investing in the future of work, PropTech, and digital healthcare. The firm supports early-stage companies and aims to back visionary founders who are transforming industries through technology. Peak State Ventures invests in seed and early-stage companies, providing both capital and strategic guidance. The firm has a diverse portfolio that includes notable companies like Snapdocs, Turing, and Mighty Buildings. Snapdocs is a leader in real estate transaction automation, while Turing democratizes the labor market by connecting U.S. companies with remote software engineers from around the world. Mighty Buildings focuses on 3D printing and sustainable construction technologies. Other portfolio companies include Feather, Brilliant, Raise, Stensul, and Ironclad. Peak State Ventures is led by a team of experienced entrepreneurs and investors. Key members include Jason Freedman, Bryan Ciambella, Omri Barzilay, Rajit Malhotra, and Seva Zakharov. They bring extensive experience in startup operations, investment, and strategic development, helping portfolio companies navigate growth challenges and achieve their business objectives.

Peak XV Partners, formerly Sequoia Capital India and Southeast Asia, is a top-tier venture capital firm with deep roots in India and Southeast Asia. Since its founding in 2006, Peak XV has become a powerhouse in the region, managing over $9 billion across 13 funds. With a portfolio of over 400 investments, including more than 50 unicorns, Peak XV has a stellar track record, having supported companies like Byju's, Truecaller, and Go Digit. The firm focuses on a broad range of industries including software, fintech, healthcare, and digital entertainment. They invest across all stages—from seed to growth—with programs like Surge supporting early-stage startups, and Build helping growth-stage companies scale sustainably. Peak XV’s team includes experienced partners from diverse backgrounds who collaborate closely with founders to help them succeed, not only through capital but also through strategic guidance, leveraging their extensive network. Based out of five key offices across Bangalore, Mumbai, Delhi, Singapore, and Dubai, Peak XV remains committed to fostering ambitious entrepreneurs who are building enduring, impactful businesses. Their mission is clear: to partner with outlier founders whose ideas have the potential to shape the future of industries.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.

Pear VC (formerly Pejman Mar Ventures) is one of Silicon Valley's most respected pre-seed and seed specialist venture firms, founded in August 2013 by Pejman Nozad and Mar Hershenson and rebranded from Pejman Mar to Pear VC in August 2016 with the launch of its $75 million Fund II. Headquartered in Menlo Park, California, the firm leads rounds and has scaled its fund platform from a $50 million first fund to $160 million (Fund III) and an oversubscribed $432 million Fund IV closed in 2023, bringing cumulative capital raised to roughly $700 million. The 25-person team includes Founding Managing Partners Pejman Nozad and Mar Hershenson and Partner Kathleen Estreich. Pear operates an explicit three-stage framework covering pre-seed through Series A and has built distinctive sourcing programs including PearX, Pear Pre-Seed Ready, and an Emerging Managers in Residence program launched in September 2024. Across 263 investments Pear has seeded three public companies: DoorDash, Guardant Health, and Senti Biosciences. Additional billion-dollar breakouts from the portfolio include Gusto, Branch, Aurora Solar, and Vanta. In 2025 the firm made 34 new investments, with seven more in the first quarter of 2026. The firm has recorded 27 portfolio exits to date, including BioAge Labs and Voyage AI. The most recent liquidity event was the exit of Breakout Audio in May 2025. Pear VC combines high-frequency seed deployment with deep programmatic engagement, running accelerator-style programs that give the firm proprietary access to emerging founders before they reach the market. The result is a sourcing advantage built over a decade of community investment in Stanford, MIT, and the broader Silicon Valley founder ecosystem.

Pebblebed is an early-stage venture capital firm founded in 2022, based in San Francisco, California. The firm focuses on investing in technology companies that demonstrate profound technical insight and have the potential to build long-term competitive advantages. Pebblebed targets investments in companies that create significant value through innovation, aiming to support startups that are capable of developing strong market positions and enduring customer relationships. Pebblebed is particularly interested in businesses that can establish deep end-user stickiness, build strong brand loyalty, or create high switching costs for customers, thereby ensuring sustainable growth and market leadership. The firm’s investment strategy is characterized by its emphasis on deep technical knowledge, leveraging the expertise of its partners who have extensive backgrounds in engineering and technology. The firm has made several investments across various sectors, including AI, computing infrastructure, and other tech-driven industries. Pebblebed’s approach is to provide more than just capital; it aims to be a strategic partner to its portfolio companies, offering guidance and resources to help them scale and succeed in competitive markets.

Pegasus Tech Ventures, based in Silicon Valley, is a global venture capital firm managing over $2 billion in assets. Founded in 2011, Pegasus offers a unique Venture Capital-as-a-Service (VCaaS) model, partnering with large corporations to invest in emerging tech startups. This involves vetting investment opportunities, managing investments, and connecting startups to a network of over 30 international corporate partners to accelerate growth. Notable investments include high-profile companies such as SpaceX, Twitter, Airbnb, SoFi, DoorDash, and 23andMe. Pegasus' diverse portfolio spans sectors like consumer electronics, automotive, healthcare, AI, and fintech, reflecting its broad investment strategy. Recently, Pegasus launched a $100 million fund with Denka Company Limited, focusing on ICT, energy, healthcare, and sustainable living. This fund aims to invest in startups across the US, Europe, Israel, and Asia, enhancing Denka's growth and innovation efforts. Additionally, Pegasus founded and sponsors the Startup World Cup, one of the largest startup competitions globally, with a $1 million investment prize. This competition supports regional innovation ecosystems worldwide and connects them to Silicon Valley. Led by founder and CEO Anis Uzzaman, Pegasus leverages its extensive global network and deep tech expertise to drive corporate innovation and help emerging tech companies achieve industry leadership.

Pelion Venture Partners, based in Salt Lake City, Utah, is a prominent venture capital firm that has been active since 1986. The firm focuses on early-stage investments in technology sectors, including enterprise software, digital media, SaaS, and cloud services. Pelion has made over 300 investments, with notable exits such as Cloudflare, Domo, and Venafi. Their investment strategy involves supporting startups with innovative solutions and strong growth potential. Pelion typically invests in seed and Series A rounds, providing the necessary capital and strategic support to help companies scale. Recent investments include companies like Jump and Cartwheel​.

Pentathlon Ventures is a Pune-based seed-stage venture capital fund founded in 2020 and dedicated exclusively to Indian B2B SaaS companies. The firm was co-founded by seven entrepreneurs and industry veterans with more than 150 years of combined operating experience: Gireendra Kasmalkar, Sandeep Chawda, Saurabh Lahoti, Madhukar Bhatia, Ashok Mayya, Hemant Joshi, and Shashank Deshpande, all drawn from companies including Globant, Clarice, Sapience, Symphony, Veritas, and Rising Pharma. This operator-heavy founding team gives Pentathlon an unusually hands-on governance and go-to-market role at the board level, which is central to the firm's positioning. Fund I closed at INR 76 Cr in August 2021 and deployed into 23 B2B SaaS startups. Fund II was launched with a headline target of INR 450 Cr and held its final close at INR 255 Cr (approximately $54.4 million) to back an additional 25 companies. Across its two funds, Pentathlon has made 31 investments. Named portfolio companies include Deeptek, Rezolve, Spyne, Dista, TurboHire, ShopSe, AyushPay, TreZix ($2 million round, January 2025), and SuperProcure (the most recent investment, in February 2026). Five new investments were executed in 2025 and one so far in 2026. The firm's investment focus covers enterprise digital transformation, e-commerce enablement, fintech, vertical SaaS, applied AI, sustainable tech, and healthtech. Pentathlon's founding philosophy holds that the best advisors for a SaaS founder are experienced SaaS operators, not career investors. The partners take an active role in product strategy, hiring, go-to-market design, and customer introductions, treating each portfolio company as a long-term partnership rather than a financial position.

Pentech Ventures is a premier venture capital firm headquartered in Edinburgh with a strong presence in London. They specialize in seed and early-stage investments, primarily targeting innovative software companies. Known for their notable exits like FanDuel, Nutmeg, and Maxymiser, Pentech has a reputation for nurturing companies that redefine their industries. Pentech focuses on UK-based startups across various software domains, including fintech, AI, and SaaS. They typically invest around £1M, often leading rounds and collaborating in syndicates. Their strategy involves not just capital infusion but also strategic guidance, leveraging their extensive network to introduce additional funding partners for subsequent growth stages. The team is led by founding partner Eddie Anderson, alongside experts like Alexander McKinnon and Craig Anderson, all based in Edinburgh. Their deep expertise spans machine learning, enterprise infrastructure, and SaaS business models, providing invaluable support to portfolio companies. For startups seeking investment, Pentech values ambitious leadership and category-defining potential. They prefer to be approached with clear, concise pitches that demonstrate strong market potential and scalability. Active and engaged, Pentech remains a dynamic force in the venture capital landscape, continuously seeking to empower the next generation of software pioneers.

People Ventures is a venture capital firm that specializes in supporting early-stage startups by taking a hands-on, operational approach. Based in Copenhagen, they focus on more than just providing capital—they actively engage with their portfolio companies by embedding a dedicated Venture Developer (VD) into the startup's team. This model allows them to stay closely involved with founders, driving commercial and operational execution from within the company. Their unique focus is on shaping and scaling innovative businesses, particularly in fields such as healthcare and tech. People Ventures is known for breaking away from traditional VC paradigms, emphasizing deep collaboration with founders to navigate the daily challenges of running a startup. Their approach enables founders to focus on scaling their businesses while benefiting from the expertise and guidance of industry experts and experienced entrepreneurs.

Perceptive Xontogeny Venture Fund (PXV) is the early-stage life-sciences venture capital platform of New York-based Perceptive Advisors, operated in strategic partnership with Boston-based accelerator and operating company Xontogeny. Perceptive Advisors launched its venture strategy with Perceptive Xontogeny Venture Fund I in 2018, an oversubscribed $210 million vehicle backed by endowments, foundations, family offices, and institutional investors. Fund II closed in May 2021 at $515 million, bringing the combined platform to more than $700 million dedicated to financing early-stage private life-sciences companies. The Investment Committee is anchored by Joe Edelman (CEO of Perceptive Advisors), Adam Stone (CIO of Perceptive Advisors), and Chris Garabedian (Portfolio Manager and Chairman and CEO of Xontogeny), alongside operating partners Fred Callori and Ben Askew, PhD. The platform leads rounds and invests typical checks of $10 million to $20 million, targeting 8 to 10 concentrated positions per fund across biotechnology, medtech, digital health, and healthcare tools and services. Across its 27 investments, PXV has backed Landos Biopharma (the first Xontogeny company, acquired by AbbVie in May 2024 as the platform's headline exit), Lexeo Therapeutics (which entered a partnership with venBio Partners in June 2025 providing up to $40 million for novel cardiac RNA therapeutics), and other early-stage therapeutics companies. Xontogeny's operating role distinguishes PXV from traditional life-sciences funds: the platform provides deep operational support from the pre-company stage through clinical and commercial scale-up, allowing the investment team to co-build companies alongside founders rather than simply writing checks and attending board meetings.

Peregrine Ventures is Israel's first dedicated healthcare-focused venture capital fund, founded in 2001 in Or Yehuda by serial entrepreneur brothers Eyal Lifschitz (Co-Founder and General Managing Partner) and Boaz Lifschitz (Co-Founder and General Partner), who previously co-founded biomedical device companies Visioncare Ophthalmic Technologies and BioControl in the 1990s. The firm today manages approximately $600 million in assets across a multi-fund platform that pairs early-stage venture investing with Peregrine Growth, a $300 million late-stage life-sciences fund launched in November 2020, plus earlier funds including a $115 million med-tech vehicle. Partners Tamir Tal, Lior Shahory, David Eldar, and Shiran Tehila Mashiah complement the founding team. A distinctive feature of the platform is its embedded synergy with the Incentive Incubator, giving portfolio companies deep operating support from the pre-company stage through clinical and commercial scale-up. Peregrine leads rounds and has made approximately 172 investments into around 75 active and realized portfolio companies, with one unicorn, one IPO, and 16 acquisitions to date. Notable outcomes include Insightec, Quicklizard, and Eledon. Startup Nation Central named Peregrine Israel's most active healthtech investor for 2024, based on 15 strategic health-tech deals. The investment scope covers life sciences broadly: healthcare, digital health, medical devices, therapeutic devices, pharma, biotechnology, and medical software. Recent investments include Lutris Pharma ($30 million, January 2025) and Aluma Healthcare in September 2025. Peregrine's 25-year track record in Israeli healthcare and its deeply integrated incubator model create a continuum from scientific concept to clinical validation that few other investors can offer. By maintaining active involvement at every stage from incubation through growth equity, the firm builds durable portfolio relationships that extend well beyond a standard investment horizon.

Perot Jain is a Dallas-based early-stage venture capital firm co-founded by Ross Perot Jr. and Anurag Jain in 2014. The firm primarily focuses on investing in innovative and disruptive startups within the healthcare, mobility, business services, and tech-enabled B2B sectors. Notable investments include companies like Access Healthcare, specializing in healthcare IT solutions, and Worlds, which creates AI-generated models for business process optimization. Other significant portfolio companies are Spacee, which offers virtual store walkthroughs, and Booster, a mobile fuel delivery service. Perot Jain typically invests up to $500,000 in seed and Series A rounds, aiming to support scalable businesses located in the United States. The firm leverages its extensive network and operational expertise to provide more than just capital, offering strategic guidance and resources to help startups achieve transformational growth. The team at Perot Jain includes a mix of founders, executives, and industry experts who work closely with entrepreneurs to drive innovation and impact. The firm has made over 70 investments and maintains a strong presence in the North Texas startup ecosystem, contributing to the region's growth as a national center for technology and innovation.

Perspectiv Ventures is a Singapore-based early-stage venture capital firm founded in 2015 and led by Managing Partner and Chief Strategist GheeHoe Cheng. The firm provides seed and early-stage funding to technology-driven ventures across three core thematic verticals: healthtech and medtech, fintech and blockchain, and AI and robotics, operating primarily across Southeast Asia with additional connectivity to the United States. Beyond capital, Perspectiv offers strategic guidance on growth, scaling, and governance in the digital business and smart-services landscape, typically participating in follow-on rounds as startups mature. The team of five includes one Partner, two Venture Partners, and one Principal, providing geographical and sectoral coverage across Singapore and the US. The firm's internal decision framework is branded 'MTTM' covering Market, Talent, Technology, and Momentum, giving its evaluation process a structured lens that goes beyond product-market fit to assess the full commercial trajectory of each investment. Perspectiv has made 13 investments across healthtech, fintech, AI, blockchain, hardware and robotics, and SaaS. Named portfolio companies include Aniday, a Southeast Asian HR and recruitment SaaS platform, and Wellcare, a clinics and outpatient-services operator. The most recent publicly documented investment is Aniday in September 2019, with no new investments publicly recorded in 2024 or 2025. Perspectiv Ventures occupies a niche as an early specialist in the Southeast Asian digital economy, having established its position in Singapore before the current wave of larger regional and international funds entered the market. GheeHoe Cheng's background in both strategic advisory and early-stage investing gives the firm a practitioner's perspective on what it takes to commercialize technology across Southeast Asia's fragmented regulatory and consumer landscape.

Peterson Ventures is a seed-stage venture capital firm that helps entrepreneurs build successful businesses from the ground up. Headquartered in Utah with an additional office in the Bay Area, Peterson Ventures focuses on SaaS, digital commerce, fintech, and healthtech sectors. The firm typically invests $250K to $1M in early-stage startups, aiming to bridge the gap between angel investors and traditional venture capital. Founded in 2008 as part of the Peterson Partners platform, Peterson Ventures has invested in over 200 companies, including notable names like Allbirds, Ethos, Lucid Software, and HireVue. The firm recently raised $140 million for its fourth fund and its first opportunity fund, allowing continued investment in their best-performing portfolio companies as they scale. The firm is led by Managing Director Ben Capell, with a team of experienced partners and associates who bring diverse backgrounds in entrepreneurship, investment banking, and corporate strategy. Peterson Ventures is known for its founder-first approach, providing not just capital but also strategic guidance and support to help startups overcome challenges and achieve growth.

Petri Bio is a biotechnology company focused on developing next-generation therapeutics derived from gut microbes. The company leverages the vast genetic information within the microbiome to discover and develop novel treatments for challenging diseases such as inflammatory bowel disease (IBD) and fatty liver disease. These diseases often have limited effective treatments, making Petri Bio's work particularly impactful. Founded by Shu Li, a Ph.D. in plant biology, and Joseph Schinaman, a biomedical researcher, Petri Bio is committed to using microbial compounds to create new medicines. Their approach involves mining microbial genomes for peptides with therapeutic potential, which they believe could lead to breakthroughs in treating various conditions that are currently underserved by existing pharmaceutical solutions. Petri Bio has also been involved in the development of treatments related to COVID-19, using their platform to identify compounds that could potentially neutralize the virus. Their work has garnered attention and interest from major pharmaceutical companies, and they continue to expand their pipeline to include other critical areas of healthcare.

Pfizer Venture Investments (Pfizer Ventures) is the corporate venture capital arm of Pfizer Inc., established in 2004 and headquartered in New York. The platform carries a $900 million total capital commitment, including a $600 million top-up announced in Q4 2021, and backs private companies at all stages of development with a strong bias toward early-stage therapeutics and platform technologies. Investment priorities mirror Pfizer's therapeutic areas: inflammation and immunology, internal medicine, oncology, and neuroscience, extending into platform technologies, diagnostics, drug delivery, pharmaceutical services, and healthcare IT. Roughly 25 percent of available capital, approximately $150 million, is explicitly earmarked for early-stage neuroscience investments. Across approximately 200 investments, Pfizer Ventures has built a concentrated neuroscience portfolio including Aquinnah, Autifony, Cortexyme, MindImmune, Mission Therapeutics, and Neuronetics. The platform leads rounds and invests globally, though deployments skew toward US-based companies. Recent notable investments include Curve Therapeutics (GBP 40.5 million Series A, led in February 2024), Enara Bio ($32.5 million Series B co-led with M Ventures in October 2024), Enlaza Therapeutics ($100 million Series A syndicate in September 2024), OTR Therapeutics ($100 million Series A for a Chinese biotech in June 2025), and Crossbow Therapeutics in March 2026 as the most recent disclosed investment. Pfizer Ventures serves as a strategic window on early-stage innovation across life sciences globally. Portfolio companies benefit not only from capital but also from Pfizer's regulatory expertise, clinical development networks, and therapeutic-area know-how, creating pathways to partnership, licensing, and acquisition that financial-only investors cannot offer.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Philips Venture Capital Fund (Philips Ventures) is the corporate venture capital arm of Royal Philips, the Dutch multinational health technology company. Founded in 1998 and based in Amsterdam at the Amstelplein 2 Breitner Tower, Philips Ventures deploys strategic capital into early- to growth-stage health technology startups whose innovations complement Philips' global healthcare portfolio and digital transformation agenda. The fund is led by Managing Partner Nate Harrington and operates with a lean two-person team at the fund level. As a corporate and strategic investor, Philips Ventures leverages Philips' deep domain expertise, global commercial footprint, and research and development capabilities to add value to portfolio companies beyond capital alone. Investment activity focuses on Series A and Series B rounds in digital software and technology-enabled healthcare services, predominantly in US-based startups with global activity. The fund has made 22 investments across healthtech, AI, and medical devices and hardware. Notable portfolio companies include PreciseDx (diagnostic equipment, latest investment as part of a Series B-II round in June 2025 as the firm's most recent disclosed deployment), Endovascular Engineering, and R3 Vascular. Recorded exits include Carevive Systems in June 2024 and ALung, acquired by LivaNova in May 2022. The firm currently states it is not investing in development-stage or pre-clinical businesses. Philips Ventures focuses on innovations that can reduce costs, improve clinical outcomes, and transform the patient and clinician experience in ways that align with Philips' strategic roadmap. Portfolio companies benefit from the potential to pilot solutions within Philips' customer network, access the firm's technical talent, and leverage its global healthcare commercial relationships across hospitals, imaging centers, and health systems worldwide.

Phoenix Capital Ventures (PCV) is an early-stage venture capital firm focusing on companies within the sports, gaming, human performance, and media industries. Leveraging over 35 years of industry experience, PCV partners with entrepreneurs to build industry-leading companies. Their investment strategy involves supporting businesses through both capital and strategic guidance, helping them scale and achieve market leadership. PCV has built an impressive portfolio, backing a range of innovative companies like Prize Picks, a popular daily fantasy sports platform, Flexia, a connected fitness company in the Pilates space, and Ghost, a sports and gaming performance brand. The firm also has a strong track record of successful exits, including companies like THUUZ and Manifest Pharmacy. Headquartered in Atlanta, PCV is led by founder and managing partner Andrew Steinberg and managing director Adam Lewites. They are supported by a diverse team of advisors, including professionals with expertise in sports, healthcare, and business development. This extensive network allows PCV to provide unique insights and resources to their portfolio companies, helping them navigate challenges and seize growth opportunities. PCV typically invests at the seed and Series A stages, offering both financial and operational support to companies that align with their vision of innovation and industry disruption. Their approach emphasizes building strong, long-term partnerships with founders to drive sustainable growth in emerging markets​.

Phoenix Venture Partners (PVP) is a Silicon Valley-based venture capital firm founded in 2009 and headquartered in San Mateo, California, with satellite offices in Singapore and Cambridge, Massachusetts. The firm specializes in taking transformative hard-technology innovations in advanced materials, novel devices, innovative manufacturing processes, and state-of-the-art tools from proof-of-concept to commercialization. Founder and Managing General Partner John Chen leads a team of seven, including five partners. PVP's core thesis targets what the firm calls Convergent Tech: the intersection of advanced materials, biology, and hardware with advanced computation and AI, investing in early-to-revenue-stage companies tackling pain points in computing, electronics, transportation, energy, industrial applications, and life sciences. Typical checks range from $100,000 to $7.5 million, and the firm leads Series A rounds. Over its 19-year history, PVP has made 85 investments, averaging two new investments per year in the last decade, and has recorded 3 IPOs and 17 acquisitions. Notable portfolio outcomes include AbSci (PVP led the 2016 Series A; AbSci listed on NASDAQ in July 2021 at a $1.45 billion market cap), NBD Nanotechnologies, and COTSWORKS (exited in July 2025). Recent investments include UbiQD (Series B-II in February 2026 as the most recent disclosed investment), Qolab (superconducting quantum computing), ORAN Development, and Nanofiber Quantum Technologies. Phoenix Venture Partners provides founders with hands-on support in business development, IP strategy, recruitment, and exit planning, leveraging a global network of strategic partners spanning manufacturing, government, and enterprise markets. Its specialist positioning in hard tech and advanced materials makes it one of the few firms capable of leading early institutional rounds in deep-science companies that require both technical diligence and long commercialization timelines.

PHX Ventures is a seed-stage venture capital firm based in Tempe, Arizona, founded in 2018 by software entrepreneur Gregg Scoresby, also the founder of CampusLogic, to fill a structural gap in the Arizona software ecosystem: institutional-quality seed capital for high-growth local B2B SaaS companies. Operating Partner Chris Chumley, previously Chief Operating Officer at CampusLogic, complements Scoresby's operating background. PHX Ventures is Arizona's most active software investor, investing exclusively in B2B SaaS and leading or co-leading seed rounds of $1 million to $5 million. The firm's sweet-spot target is Arizona-based B2B SaaS companies with annual recurring revenue of $100,000 to $1 million that are on a credible path to institutional growth. PHX Ventures' oversubscribed Fund II closed at $25.4 million in 2023, backed by successful Arizona software entrepreneurs, executives, advisers, and principals from top-tier US growth-equity firms. The firm also operates a venture studio that builds SaaS companies in-house and has a goal of investing in 30 B2B software companies by 2030. As of 2025, PHX has made 16 or more investments with 12 Arizona-headquartered companies. Portfolio companies span enterprise applications, vertical SaaS, fintech, healthtech, and AI. Named portfolio companies include Rivia Health, Better Agency, Nurture Boss, RTA/Fleet360 (Series A in April 2025), and Fluint (most recent disclosed investment in August 2025). PHX Ventures combines founder-operator credibility with proximity to the Arizona tech ecosystem, bringing a practical understanding of software business-building rather than purely financial expertise. Its fund-plus-studio model gives it access to both market-sourced deals and proprietary company creation, expanding the pipeline relative to a traditional seed fund.

Phyto Partners is a venture capital firm based in Boca Raton, Florida, focused on the cannabis industry. Since its founding in 2015, the firm has invested in around 30 companies across the cannabis value chain. Their strategy prioritizes ancillary businesses, which provide essential solutions to support licensed operators, such as advertising technology, agricultural innovations, biotechnology, SaaS, and medical dosing technology. Phyto Partners takes an active role beyond just providing capital, offering strategic support, networking, and business development assistance to help their portfolio companies grow. Their investments span various sectors, including branded products, cannabis delivery services, and data analytics. The firm is known for helping companies navigate the highly regulated cannabis market, seeing compliance and technology solutions as key growth areas. In addition to their cannabis focus, Phyto Partners has expanded into brain health and psychedelics with their "Phyto Psyche" fund, recognizing the growing interest in neurowellness and mental health treatments.

Pi Campus is a venture capital firm based in Rome, Italy, that specializes in investing in early-stage startups focused on artificial intelligence (AI) and tech innovations. Founded by Marco Trombetti, Isabelle Andrieu, and Gianluca Granero, Pi Campus originated from Translated, a pioneering AI-driven translation service. The firm primarily invests in startups that apply AI to disrupt traditional industries, especially those perceived as slow-moving, and supports them with funding, mentorship, and access to a vast international network. Pi Campus typically invests between €50,000 and €500,000 in exchange for equity stakes of 1% to 10%, targeting startups in Europe and the U.S. with a strong focus on AI applications. Their portfolio includes companies like Boom Supersonic, which is working on sustainable supersonic travel, and Skymind, an AI ecosystem builder. In addition to financial investment, Pi Campus provides a nurturing environment for startups, including workspace in luxury villas converted into offices, and mentorship through their School of AI, which trains engineers on real-world problems with the support of global tech leaders like Google and Facebook. Pi Campus places a significant emphasis on fostering innovation and diversity, offering a collaborative platform for AI enthusiasts and entrepreneurs who combine design, technology, and emotional intelligence to create impactful products​.

Pi Ventures, founded in 2016 and based in Bengaluru, India, is a venture capital firm focused on early-stage investments in deep tech startups. The firm specializes in sectors such as artificial intelligence, machine learning, the Internet of Things (IoT), and healthcare. Notable investments by Pi Ventures include companies like Agnikul, an aerospace startup; SwitchOn, which focuses on industrial automation and machine learning; and Zero Cow Factory, a biotech company developing sustainable food products. Pi Ventures has invested in a total of 42 companies and has made significant exits, including Zenatix Solutions through a merger and acquisition. The firm was founded by Manish Singhal and Umakant Soni, and the leadership team includes Managing Directors Roopan Aulakh and Shubham Sandeep. Pi Ventures is known for backing innovative startups and supporting them through their growth phases with a combination of capital and strategic guidance.

Picus Capital, founded in 2015 and headquartered in Munich, Germany, is an early-stage venture capital firm with a long-term investment philosophy. The firm focuses on technology-driven sectors such as financial services, HR, energy & climate, healthcare, logistics & mobility, real estate & construction, crypto & web3, deep tech, and e-commerce. Picus Capital has made significant investments in companies like Ledge, Spot My Energy, Cove Living, Poolit, and Alasco, among others. Their portfolio spans across 20+ countries with a diverse range of startups that are innovating in their respective fields. The firm's unique approach emphasizes close partnerships with their portfolio companies, assisting them with strategic decisions and operational challenges. With offices in Munich, London, New York, Beijing, and other key locations, Picus Capital is well-positioned to support global growth and expansion. The firm is led by co-founders Robin Godenrath, Alexander Samwer, and Jeremias Heinrich, who bring extensive experience and a strong entrepreneurial mindset to the table. Their team is dedicated to helping daring technology companies build successful, global enterprises that challenge the status quo and shape the future​

Pier 70 Ventures is a venture capital firm based in Seattle, launched in 2020 by former Boeing executives with a focus on healthcare and med-tech innovation. The firm operates with a mission to fund impact-driven companies, especially those leveraging AI, data, and cloud technologies to reshape healthcare. Pier 70 is particularly known for supporting diverse leadership teams and sees diversity as a key driver for financial returns. Their areas of interest include digital health, diagnostics, and med-tech. The founding team, which includes industry veterans like R. Miller Adams, Shaun Hawkins, and Bob Balk, brings deep expertise from both the corporate and investment worlds. For example, Adams and Balk developed Boeing’s venture capital arm, growing it into a $250 million fund-of-funds. At Pier 70, they aim to replicate this success by connecting startups with a global network of healthcare leaders, corporate investors, and biopharma companies. Pier 70's initial fund, the INpact Fund, focuses on early-stage to Series B investments, with check sizes ranging from $250,000 to $2 million. The firm is committed to fostering innovation and reducing economic inequality by backing underrepresented entrepreneurs. They’ve already made notable investments in startups like DocSpera, a surgical coordination platform, and Acclinate, a company focused on increasing diversity in clinical trials. Pier 70 aims to fund up to 22 companies with its first fund, contributing not just capital but strategic guidance to help startups scale and thrive.

Pillar VC is a venture capital firm based in Boston, Massachusetts, specializing in early-stage investments, particularly in pre-seed and seed rounds. Founded in 2016, the firm focuses on supporting founders from the very beginning, often before formal incorporation, and invests in various sectors including AI/ML, biotech, consumer, enterprise, fintech, and crypto/web3. Pillar VC manages multiple funds, including the recent $192 million raised for Pillar III and Pillar Select. This allows them to continue backing companies with significant potential to become foundational pillars of their industries. Their investment strategy includes leading seed rounds with investments ranging from $2 million to $6 million and making pre-seed investments between $50,000 and $500,000. The firm is distinguished by its commitment to buying common stock to align closely with the founders' interests. Pillar VC also provides robust support through a dedicated platform team that assists with talent acquisition, expert connections, pitch polishing, and investor introductions. This approach has helped foster successful companies like Algorand, Desktop Metal, and PillPack​.

Ping An Ventures is the corporate venture capital arm of Ping An Insurance (Group) Company of China, one of China's largest insurance and financial services conglomerates. Founded in 2012 with RMB 1 billion (~$150 million) of seed capital from Ping An Insurance, the firm is headquartered in Pudong, Shanghai and holds the distinction of being the first VC fund launched out of China's financial industry. Ping An Ventures invests across fintech, healthcare, consumer, and technology verticals — spanning domestic and overseas opportunities — with a focus on middle-to-late growth rounds, pre-IPO, and PIPE transactions that align with Ping An's own digital transformation roadmap. The firm has made approximately 160 investments across its history, with check sizes typically ranging from $3 million to $50 million. To extend its global reach, Ping An Ventures launched the Hong Kong-based Global Voyager fund at $1 billion to source healthcare and fintech assets in the United States, Israel, and Singapore, and has targeted up to $1.3 billion across two additional healthcare-focused growth-stage funds. Notable portfolio companies include Didi Chuxing, Meituan-Dianping, Oscar Health, Payoneer, Taulia, Hycor Biomedical, Fabric Genomics, and Tmunity Therapeutics. Recent exits include eToro and Fabric Genomics, acquired by GeneDx for $51 million in April 2025. Ping An Ventures operates with a lean team of eight investment professionals and maintains a disciplined approach to portfolio construction, concentrating on companies where Ping An's insurance, fintech, and healthcare networks create tangible strategic advantage. The firm functions as both a financial investor and a strategic partner, connecting portfolio companies to Ping An's vast distribution ecosystem across China and select global markets.

Pink Salt Ventures, founded in 2019, is the UK's first venture capital firm dedicated exclusively to investing in female-led startups. Headquartered in London, the firm focuses on early-stage investments, particularly in the technology, wellness, and femtech sectors. Pink Salt Ventures partners with female entrepreneurs building innovative solutions across health, sextech, and wellness, with investment sizes typically ranging from €100,000 to €1.5 million. Founded by Samira Qassim and Saloni Bhojwani, Pink Salt Ventures aims to address the significant funding gap faced by female founders in Europe. Their approach goes beyond just providing capital; they emphasize mentorship, strategic guidance, and long-term partnership to help entrepreneurs build impactful, lasting businesses. The firm’s ethos is centered on backing founders who display grit, resilience, and an unstoppable drive to succeed. Pink Salt Ventures has already supported a number of promising startups, including MPowder, a menopause-focused health brand, Juno Bio, which decodes the vaginal microbiome, and Mirza, a platform aimed at bridging the financial gap in childcare. The firm’s impact-focused strategy seeks to elevate female founders, who have historically been underrepresented in venture capital, while delivering strong returns​.

Pinnacle Ventures is a Burlingame, California-based investment firm founded in 2002 that specializes in providing both venture debt and venture equity financing to high-growth companies across the United States. Led by principals Kenneth R. Pelowski and Robert N. Savoie, the firm operates as investment manager and adviser to a family of venture debt and equity funds — including Pinnacle Ventures Debt Fund III, whose limited partners include The Prudential Insurance Company of America. While sector-agnostic, Pinnacle concentrates its activity in clean technology, healthcare, and information technology, with particular emphasis on internet, mobile, media, enterprise, and software companies. Pinnacle writes venture-debt checks from $500,000 up to $25 million and venture-equity checks up to $15 million, offering founders flexible growth-capital solutions that complement equity rounds without undue dilution. Across 177 investments in 137 unique portfolio companies, the firm has produced 2 unicorns and 98 exits — a strong track record for a venture-debt-led platform. Notable portfolio companies include One Medical, Bonobos, and Kabam. The firm's most recent disclosed investment was a $50 million Series C round in VOOX in January 2025, and its most recent exit was Lotame, acquired by Publicis Groupe in March 2025. Pinnacle's dual debt-plus-equity model is central to its value proposition: by combining venture loans with equity participations, the firm can tailor capital structures to each company's growth trajectory and founder preferences. This flexibility positions Pinnacle as a complement to traditional equity-only VCs and allows founders to preserve dilution while accessing growth runway. The firm's long operating history since 2002 gives it a broad perspective across market cycles.

Pinto Ventures AG is a Swiss seed-stage venture capital and company-building firm founded in 2019 and headquartered in Walchwil in the canton of Zug. The firm is structured as a single-LP fund and is led by Founder Joao Monteiro, formerly VP of New Business at global logistics giant Kuehne + Nagel. Pinto focuses on angel and pre-seed to seed investments in founders building across fintech, logistics technology, healthtech, and retail, with a deliberate geographic concentration on Europe. Check sizes range from approximately $250,000 to $5 million. Pinto Ventures has made roughly 15 investments over its history, and two portfolio companies have been acquired: Monese, a UK challenger bank, and VONZU, a SaaS delivery-management platform. Other notable portfolio investments include eTEU (maritime and logistics software), Roundabout (marketplace), and XYB (financial software). Co-investors across Pinto's deals include Kinnevik, PayPal, Speedinvest, Global Founders Capital, HSBC, Investec, Cavalry Ventures, and Axa Venture Partners — demonstrating strong alignment with top-tier European and global VCs. Pinto positions itself as a capital-plus-craft investor: bringing time, capital, and access together in equal measure. The firm offers hands-on collaborative support to founders via impactful introductions across key business areas and operates with what it calls 'skin in the game' — its own principals are actively engaged in the commercial development of each portfolio company rather than serving purely in a board-oversight capacity. The team of two partners keeps the portfolio concentrated and ensures close attention to each founder relationship.

Pioneer Fund, founded in 2017, is a venture capital firm based in San Francisco, CA, and Toronto, Canada. This unique fund is driven by over 400 Y Combinator alumni, focusing on investing in top startups that emerge from the Y Combinator accelerator. With a strong emphasis on early-stage investments, Pioneer Fund supports a diverse range of industries, including consumer products, financial services, AI, life sciences, and education technology. Notable investments by Pioneer Fund include companies like Aspire, C16 Biosciences, Curebase, Dover, and OnDeck, reflecting their broad and impactful portfolio. The fund has made over 600 investments and continues to actively support new ventures, emphasizing their commitment to fostering innovation and growth in the startup ecosystem. Pioneer Fund operates with a flexible and founder-friendly approach, often providing quick investment decisions. They also maintain a global investment perspective, with a presence in countries such as India, Nigeria, Argentina, and Chile. This geographical diversity enables them to back startups with international ambitions and scalability. The team at Pioneer Fund is led by founder Daniel Gross, along with other notable members such as Tim Suzman and Rajiv Bhat. They bring a wealth of experience and connections, leveraging their backgrounds as Y Combinator alumni to provide valuable mentorship and support to portfolio companies.

Pique Ventures is a Vancouver, British Columbia-based impact investment firm founded in 2012 by Bonnie Foley-Wong, a chartered accountant and CFA charterholder who has been a longtime advocate for impact investing. Pique pioneered the concept of 'Integrated Investing' — a methodology for making mindful investment decisions that balance financial, social, and systemic impact. In 2014, the firm launched the Pique Fund, structured as a British Columbia Venture Capital Corporation and focused explicitly on leadership diversity in technology. The Pique Fund raised over CAD 6 million of public- and private-sector capital from 41 investors, 32 of whom are women — representing roughly 75% of committed capital. The fund invested in 7 women-founded BC-based technology ventures at seed and Series A stages across fintech, healthcare, SaaS, and consumer sectors. Notable portfolio companies include Beanworks (accounts payable automation, with Pique co-investing in a $10.1 million Series B led by FINTOP Capital and BDC Capital's Women in Technology Venture Fund), ePACT Network (emergency information sharing), FoodMesh (online marketplace for surplus food), and Careteam (care coordination software). Pique's investment philosophy treats diversity not as a social obligation but as a return-generating signal: the firm's thesis holds that women-led and gender-mixed teams demonstrably outperform across key financial metrics. Bonnie Foley-Wong remains the firm's primary voice on impact-investing thought leadership and has extended the Pique brand into advisory and educational work following the full deployment of its primary fund.

Pirveli Ventures is a Montreal-based family fund that focuses on early-stage investments, particularly in Israeli startups. The fund is known for its laid-back, hands-on approach, providing both initial and follow-on investments while actively supporting portfolio companies in areas like strategy, business development, and management. This close involvement allows Pirveli to act as an extension of the startup teams they back. Their investments typically center around sectors such as agricultural tech, health tech, sustainability, and automotive technologies. Notable companies in their portfolio include Gordian Surgical, Eco Wave Power, and Flora Fotonica, reflecting a commitment to innovative, high-impact ventures. Pirveli Ventures generally invests in the seed stage, and while they do not limit themselves to a specific check size, they are comfortable co-investing alongside other funds. Their investment philosophy focuses on working with startups that have a clear business plan and strong management teams, helping them transition from innovative ideas to successful companies​.